GOLM1 and neoplasm: Indicators that were statistically significant (P < 0.05) were included in the multivariate logistic regression analysis, the results of which revealed that the serum GP73 level was an independent factor for tumor response to lenvatinib treatment (P < 0.001) (Table S3).